Clinical features and outcome in North American adults with moyamoya phenomenon

被引:271
作者
Hallemeier, Christopher L.
Rich, Keith M.
Grubb, Robert L., Jr.
Chicoine, Michael R.
Moran, Christopher J.
Cross, DeWitte T., III
Zipfel, Gregory J.
Dacey, Ralph G., Jr.
Derdeyn, Colin P.
机构
[1] Washington Univ, Sch Med, Intervent Neuroradiol Sect, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
关键词
cerebral hemorrhage; cerebral infarction; cerebral revascularization; moyamoya disease; retrospective studies;
D O I
10.1161/01.STR.0000221787.70503.ca
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose - To describe baseline clinical features and outcomes of adults with moyamoya phenomenon treated at a single North American institution. Methods - We identified 34 adults with moyamoya phenomenon by review of angiographic records. Clinical presentation and baseline stroke risk factors were obtained by chart review. Follow-up was obtained prospectively. A 5-year Kaplan-Meier stroke risk was calculated. Results - The median age was 42 (range 20 to 79) years. Twenty-five were women. The initial symptom was ischemia, hemorrhage, or asymptomatic in 24, 7, and 3 patients, respectively. Twenty-two had bilateral involvement and 12 had unilateral moyamoya vessels. Baseline stroke risk factors were similar between groups. The median follow-up in 31 living patients was 5.1 (range 0.2 to 19.6) years. Fourteen patients were treated with surgical revascularization (20 total hemispheres). In medically treated symptomatic hemispheres, the 5-year risk of recurrent ipsilateral stroke was 65% after the initial symptom and 27% after angiographic diagnosis. Patients with bilateral involvement presenting with ischemic symptoms were at the highest risk of subsequent stroke (n = 17, 5-year risk of stroke with medical treatment after first symptom of 82%). In surgically treated hemispheres, the 5-year risk of perioperative or subsequent ipsilateral stroke or death was 17%. This was significantly different compared with medical treatment after first symptom (P = 0.02) but not after angiographic diagnosis. Conclusion - Moyamoya phenomenon in North American adults is associated with a high risk of recurrent stroke, particularly those with bilateral involvement and ischemic symptoms. These data suggest a potential benefit with surgery if diagnosis could be made earlier.
引用
收藏
页码:1490 / 1496
页数:7
相关论文
共 25 条
[1]   RECOVERY OF MOTOR FUNCTION AFTER STROKE [J].
BONITA, R ;
BEAGLEHOLE, R .
STROKE, 1988, 19 (12) :1497-1500
[2]   CEREBRAL INFARCTION DUE TO MOYAMOYA DISEASE IN YOUNG-ADULTS [J].
BRUNO, A ;
ADAMS, HP ;
BILLER, J ;
REZAI, K ;
CORNELL, S ;
ASCHENBRENER, CA .
STROKE, 1988, 19 (07) :826-833
[3]   Clinical features of Moyamoya disease in the United States [J].
Chiu, D ;
Shedden, P ;
Bratina, P ;
Grotta, JC .
STROKE, 1998, 29 (07) :1347-1351
[4]   Idiopathic supraclinoid and internal carotid bifurcation steno-occlusive disease in young American adults [J].
Cloft, HJ ;
Kallmes, DF ;
Snider, R ;
Jensen, ME .
NEURORADIOLOGY, 1999, 41 (10) :772-776
[5]   Compensatory mechanisms for chronic cerebral hypoperfusion in patients with carotid occlusion [J].
Derdeyn, CP ;
Videen, TO ;
Fritsch, SM ;
Carpenter, DA ;
Grubb, RL ;
Powers, WJ .
STROKE, 1999, 30 (05) :1019-1024
[6]   Cerebral hemodynamic impairment - Methods of measurement and association with stroke risk [J].
Derdeyn, CP ;
Grubb, RL ;
Powers, WJ .
NEUROLOGY, 1999, 53 (02) :251-259
[7]  
Fukui M, 1997, CLIN NEUROL NEUROSUR, V99, pS238
[8]   Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion [J].
Grubb, RL ;
Derdeyn, CP ;
Fritsch, SM ;
Carpenter, DA ;
Yundt, KD ;
Videen, TO ;
Spitznagel, EL ;
Powers, WJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (12) :1055-1060
[9]   Hemodynamic reserve and high- intensity transient signals in Moyamoya disease [J].
Horn, P ;
Lanczik, O ;
Vajkoczy, P ;
Daffertshofer, M ;
Bueltmann, E ;
Werner, A ;
Schmiedek, P ;
Hennerici, M .
CEREBROVASCULAR DISEASES, 2005, 19 (03) :141-146
[10]  
Ikezaki K, 1997, CLIN NEUROL NEUROSUR, V99, pS173